SCHEMBL6153463

SCHEMBL6153463

CC(C)(C)OC(=O)N[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.69
GAA P10253 1/20 0.69
TSHR P16473 1/20 0.66
EPHX1 P07099 1/20 0.59
KMT2A Q03164 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
KDM1A O60341 1/20 0.57
MAOB P27338 1/20 0.57
DPP4 P27487 3/20 0.54
DPP7 Q9UHL4 3/20 0.54
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
ACHE P22303 2/20 0.54
KCNH2 Q12809 1/20 0.54
SYK P43405 1/20 0.53
CTSL P07711 1/20 0.53
CTSB P07858 1/20 0.53
CTSK P43235 1/20 0.53
MEN1 O00255 1/20 0.51
DRD2 P14416 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3944464 1.00 ALDH1A1 (0.69) ALDH1A1GAATSHREPHX1KMT2A
SCHEMBL3944460 1.00 ALDH1A1 (0.69) ALDH1A1GAATSHREPHX1KMT2A
SCHEMBL2291956 0.95 ALDH1A1 (0.62) ALDH1A1GAATSHREPHX1KMT2A
SCHEMBL4929443 0.95 ALDH1A1 (0.62) ALDH1A1GAATSHREPHX1KMT2A
SCHEMBL4929457 0.95 ALDH1A1 (0.62) ALDH1A1GAATSHREPHX1KMT2A
SCHEMBL14010470 0.95 ALDH1A1 (0.62) ALDH1A1GAATSHREPHX1KMT2A
SCHEMBL15653913 0.94 ALDH1A1 (0.64) ALDH1A1GAATSHREPHX1KMT2A
SCHEMBL15653914 0.94 ALDH1A1 (0.64) ALDH1A1GAATSHREPHX1KMT2A
Hydrochloric Acid SCHEMBL17106886 0.92 ALDH1A1 (0.63) ALDH1A1GAATSHREPHX1KMT2A
Hydrochloric Acid SCHEMBL17106887 0.92 ALDH1A1 (0.63) ALDH1A1GAATSHREPHX1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 ALDH1A1 2454/4885GAA 2875/4885TSHR 1583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.